Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA

Sponsor
Ospedale Edoardo Bassini (Other)
Overall Status
Recruiting
CT.gov ID
NCT06147401
Collaborator
(none)
60
1
2
5.4
11.2

Study Details

Study Description

Brief Summary

Optimal pain control with limited muscle weakness is paramount for a swift initiation of physical therapy and ambulation. Fascia iliaca compartment block (FIC) has been recommended since it offers the best pain control with low risk of motor block. Pericapsular nerve group block (PENG) with lateral femoral cutaneous block (LFCN) has been proposed as an effective alternative to FIB that offers similar pain control with a considerably lower risk of motor block. The aim of this study is to compare the afore mentioned blocks and determine which one yielded the least degree of quadriceps femoris muscle weakness and the better pain control (the lowest NRS score with least need for opioids).

Condition or Disease Intervention/Treatment Phase
  • Procedure: PENG plus LFCN block
  • Procedure: FIC Block
N/A

Detailed Description

This single-center, double blinded RCT investigation will be conducted at ASST Nord Milano - Bassini hospital. The study was approved by the ethics committee "Comitato Etico Territoriale Lombardia 3".

Each patient undergoing elective total hip replacement surgery with lateral approach will be subjected (unless contraindicated) to subarachnoid neuraxial anesthesia and immediately afterwards to a peripheral analgesic block: the FIC block or the association of PENG and FCLN block. The choice of block type will be randomized.

At the end of the procedure, a clinician unaware of the anesthetic technique used will assess the degree of residual motor block. Simultaneously, he will assess pain control in terms of NRS (Numerical Rating Scale) and the need for opioid use.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A double-blind, randomized, controlled trialA double-blind, randomized, controlled trial
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
The anesthetist in the operating room will be the only one who knows what treatment has been administered Participant: the patient will not know the type of block he will be subjected to, because of he will already be subjected to neuraxial anesthesia. Outcomes Assessor: a clinician external to the practice will evaluate the degree of residual paralysis after anesthesia and pain control Investigator: the statistician will not know which anesthetic technique was administered to which group
Primary Purpose:
Treatment
Official Title:
Comparison of Pericapsular Nerve Group (PENG) Block Associated With Lateral Femoral Cutaneous Nerve (LFCN) Block Versus Fascia Iliaca Compartment Block (FICB) for Multimodal Analgesic Management in Total Hip Replacement Surgery: a Double-blinded Randomized Controlled Trial
Actual Study Start Date :
Nov 20, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: PENG - LFCN Block

group in which PENG and LFCN Block was performed. After performing neuraxial anesthesia, the PENG associated with LFCN block will be performed. Under ultrasound guidance, 20ml and 5ml of Ropivacaine 0.5% will be administered respectively.

Procedure: PENG plus LFCN block
The experimental arm will be subjected to a combination of peripheral blocks: the interfascial block of the PENG and the perinervous block of the LFCN The PENG block involves deposition of local anesthetic in the fascial plane between the psoas muscle and the superior pubic ramus. The LFCN block consists of applying local anesthetic near the nerve. The LFCN lies in the subcutaneous plane deep to the fascia lata below the anterior superior ischiatic spine.
Other Names:
  • Pericapsular nerve group block and lateral femoral cutaneous nerve block
  • PENG and lateral femoral cutaneous nerve block
  • Active Comparator: FIC Block

    group in which FIC Block was performed After performing neuraxial anesthesia, FIC block will be performed. Under ultrasound guidance, 20 ml of Ropivacaine 0.5% will be administered.

    Procedure: FIC Block
    The control arm will be subjected to an interfascial block, the fascia iliaca Compartment Block. The FICB consists in the injection of anaesthetic agents into the fascia iliaca compartment.
    Other Names:
  • Fascia Iliaca Compartment Block
  • FICB
  • Outcome Measures

    Primary Outcome Measures

    1. MRC at 6h [six hours after performing the regional anesthesia technique]

      evaluation of the degree of weakness or residual paresis of the quadriceps femoris muscle on the operative side using 'the Oxford Scale' (aka Medical Research Council Manual Muscle Testing scale or MRC scale) The MRC scale is a 0-5 scale, with zero meaning "no contraction " and five meaning "Full range of motion against gravity with full resistance".

    2. MRC at 24h [24 hours after performing the regional anesthesia technique]

      evaluation of the degree of weakness or residual paresis of the quadriceps femoris muscle on the operative side using 'the Oxford Scale' (aka Medical Research Council Manual Muscle Testing scale or MRC scale) The MRC scale is a 0-5 scale, with zero meaning "no contraction " and five meaning "Full range of motion against gravity with full resistance".

    3. MRC at 48h [48 hours after performing the regional anesthesia technique]

      evaluation of the degree of weakness or residual paresis of the quadriceps femoris muscle on the operative side using 'the Oxford Scale' (aka Medical Research Council Manual Muscle Testing scale or MRC scale) The MRC scale is a 0-5 scale, with zero meaning "no contraction " and five meaning "Full range of motion against gravity with full resistance".

    Secondary Outcome Measures

    1. time to first postoperative ambulation [From date of surgery until up to 72 hours after]

      we studied the effect or Regional anesthesia on residual paralysis

    2. Pain control at 6h [six hours after performing the regional anesthesia technique]

      pain assessment with Numeric Rating Scale (NRS): a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    3. Pain control at 24h [24 hours after performing the regional anesthesia technique]

      pain assessment with Numeric Rating Scale (NRS): a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    4. Pain control at 48h [48 hours after performing the regional anesthesia technique]

      pain assessment with Numeric Rating Scale (NRS): a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable"

    5. MME of PRN opioid total doses [From date of surgery until up to 72 hours after]

      Morphine Milligram Equivalents (MME) of "pro re nata" (PRN) opioid total doses we will study the effect of Regional anesthesia on opioid-sparing with the same pre-established pain relief protocol

    6. time to first PRN opioid request [From date of surgery until up to 72 hours after]

      time to first PRN (pro re nata) opioid request expressed in minutes

    7. need for PRN opioid [From date of surgery until up to 72 hours after]

      number of opioid administration

    Other Outcome Measures

    1. Complication [From date of surgery until up to 72 hours after]

      any complications recorded in the first 72 hours including but not limited to: postoperative nausea and vomiting (PONV), vascular puncture, paresthesia and LA toxicity

    2. the degree of hip flexion [six hours after performing the regional anesthesia technique]

      Hip flexion degree of the operative side is measured using Digital Angle Gauge in supine position

    3. the degree of hip flexion [24 hours after performing the regional anesthesia technique]

      Hip flexion degree of the operative side is measured using Digital Angle Gauge in supine position

    4. the degree of hip flexion [48 hours after performing the regional anesthesia technique]

      Hip flexion degree of the operative side is measured using Digital Angle Gauge in supine position

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • elective total hip replacement surgery for non-traumatic hip disease,

    • THA (total hip arthroplasty) with lateral approach

    • age >18 years,

    • signed consent form for spinal anesthesia and peripheral nerve block provided by the patient or legal guardian if appointed

    Exclusion Criteria:
    • Non elective THA

    • Lack of consent to the procedure

    • Contraindications to performing neuraxial anesthesia (i.e. Signs suggestive of puncture site infection, INR > 1.5, aPTT > 1.5, PLT < 40.000)

    • Documented or suspected allergy to local anesthetics

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ospedale Edoardo Bassini Cinisello Balsamo Milano Italy 20092

    Sponsors and Collaborators

    • Ospedale Edoardo Bassini

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Francesco Vetrone, Principal Investigator, Ospedale Edoardo Bassini
    ClinicalTrials.gov Identifier:
    NCT06147401
    Other Study ID Numbers:
    • 3703
    First Posted:
    Nov 27, 2023
    Last Update Posted:
    Nov 27, 2023
    Last Verified:
    Nov 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Francesco Vetrone, Principal Investigator, Ospedale Edoardo Bassini
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 27, 2023